Room | Room 1 | Room 2 | Room 3 | Room 4 | Room 5 |
---|---|---|---|---|---|
16:00~18:00 | Symposium (K) | Symposium | |||
Evolution of Big Data in Contemporary Healthcare Services | Immune Regulation of Cardiovascular Disease | ||||
18:00~ | Welcome Reception |
Room | Room 1 | Room 2 | Room 3 | Room 4 | Room 5 |
---|---|---|---|---|---|
08:00~09:00 | Breakfast Symposium 1 | Breakfast Symposium 2 | Breakfast Symposium 3 | ||
09:00~09:30 |
Keynote Lecture 1 Killer Clones: Clonal Hematopoiesis as a New Causal Risk Factor for Cardiovascular Disease Kenneth Walsh (University of Virginia, USA) |
||||
09:30~09:40 | Break | ||||
09:40~11:10 | Symposium | Symposium | Symposium | Symposium | |
Now It's Time to Focus on Variability | Beyond LDL-C : What Can Improve Dyslipidemia Care? | Evidenced-Based Dietary Guidelines for CVD (Dyslipidaemia) Prevention | Single Cell Analysis | ||
11:10~11:20 | Coffee Break | ||||
11:20~11:30 | Opening Address | ||||
11:30~12:10 |
Plenary Lecture 1 The Benefits of GLP 1-RA and SGLT2 Inhibitor for the CV Outcomes: What is Similar or Different? Stefano Del Prato (University of Pisa, Italy) |
||||
12:10~13:10 | Luncheon Symposium 1 | Luncheon Symposium 2 | Luncheon Symposium 3 | Luncheon Symposium 4 | |
13:10~13:20 | Break | ||||
13:20~13:50 | Special Lecture 1 Metabolic Reprogramming of Macrophage in Atherosclerosis: Is it All about Cholesterol? Laurent Yvan-Charvet (Centre Méditerranéen de Médecine Moléculaire, France) |
||||
13:50~14:00 | Break | ||||
14:00~15:30 | Symposium | Symposium | Symposium | Symposium (KSoLA-JAS) |
Publication Committee Session |
Hot Issues in Recent Lipid Guidelines | Recent Evidence and Clinical Applications of Arterial Stiffness | Novel Approaches in Lipidology and Atherosclerosis | Use of Non-statin Lipid-lowering Agents for Residual Risk Management | Top Articles of 2019 in the JLA | |
15:30~16:30 | Oral Presentation / Moderated Poster Presentation | ||||
16:30~18:00 | Symposium | Symposium | Symposium | Symposium (KSoLA-IAS) |
|
Glucose Metabolism and Cardiovascular Disease | Blood Pressure in Lipid and Atherosclerosis | Reappraisal of Immune Cells in Cardiovascular Disease | Lipoprotein(a), a Crucial but Forgotten Risk Factor for Cardiovascular Disease | ||
18:00~18:10 | Break | ||||
18:10~ | Dinner |
Room | Room 1 | Room 2 | Room 3 | Room 4 | Room 5 |
---|---|---|---|---|---|
08:00~09:00 | Breakfast Symposium 4 | Breakfast Symposium 5 | Breakfast Symposium 6 | ||
09:00~09:30 | Keynote Lecture 2 Metformin: Is it a Cardiovascular Drug? Gregory G. Schwartz (University of Colorado, USA) |
||||
09:30~09:40 | Break | ||||
09:40~11:10 | Symposium | Symposium | Symposium | Symposium | Symposium (KSoLA-Thailand) |
Things to Consider When We Treat Dyslipidemia | New Concept of HDL | Dietary Supplements for Prevention of CVD | Bioactive Lipids and Diseases | TBD | |
11:10~11:30 | Coffee Break | ||||
11:30~12:10 | Plenary Lecture 2 My Sweet Heart Was Broken: Fat Metabolism and Diabetes in the Heart Ira J. Goldberg (New York University, USA) |
||||
12:10~13:10 | Luncheon Symposium 5 | Luncheon Symposium 6 | Luncheon Symposium 7 | Luncheon Symposium 8 | |
13:10~13:20 | Break | ||||
13:20~13:50 | Special Lecture 2 Cardiovascular Risk Factors - It's Time to Focus on Variability Sripal Bangalore (New York University, USA) |
||||
13:50~14:00 | Break | ||||
14:00~15:00 | Oral Presentation / Moderated Poster Presentation | ||||
15:00~15:20 | Coffee Break | ||||
15:20~16:50 | Symposium | Symposium | Symposium | Symposium (KSoLA-EAS) |
|
Issused of Low LDL Cholesterol | Air Pollution on Cardiovascular Disease | Targeting New Pathways to Treat Atherosclerotic Cardiovascular Disease | Familial Hypercholesterolemia is not Far Away | ||
16:50~ | Closing Ceremony |